Paper38737101
Therapeutic developments for neurodegenerative GM1 gangliosidosis.
Foster D and 3 others. Front Neurosci, 2024. Cited by 16 papers, by iCite.
Cite this record
ConductScience Library. Therapeutic developments for neurodegenerative GM1 gangliosidosis. Papers, record 38737101. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38737101
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R21 NS133477 | NINDS NIH HHS | United States | R21NS133477 | PubMed and NIH |
Source NIH RePORTER
References51
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37526361 | Life-Limiting Peripheral Organ Dysfunction in Feline Sandhoff Disease Emerges after Effective CNS Gene Therapy. | Ann Neurol | 2023 | https://conductscience.org/library/papers/37526361 | PubMed |
| 2 | 18387328 | Beneficial effects of substrate reduction therapy in a mouse model of GM1 gangliosidosis. | Mol Genet Metab | 2008 | https://conductscience.org/library/papers/18387328 | PubMed |
| 3 | 8132559 | N-butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis. | J Biol Chem | 1994 | https://conductscience.org/library/papers/8132559 | PubMed |
| 4 | 10021458 | A genetic model of substrate deprivation therapy for a glycosphingolipid storage disorder. | J Clin Invest | 1999 | https://conductscience.org/library/papers/10021458 | PubMed |
| 5 | 15941905 | Chemokine-induced recruitment of genetically modified bone marrow cells into the CNS of GM1-gangliosidosis mice corrects neuronal pathology. | Blood | 2005 | https://conductscience.org/library/papers/15941905 | PubMed |
| 6 | 15262262 | Improved outcome of N-butyldeoxygalactonojirimycin-mediated substrate reduction therapy in a mouse model of Sandhoff disease. | Neurobiol Dis | 2004 | https://conductscience.org/library/papers/15262262 | PubMed |
| 7 | 37298512 | Ganglioside GM1 and the Central Nervous System. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37298512 | PubMed |
| 8 | 31970203 | 7T MRI Predicts Amelioration of Neurodegeneration in the Brain after AAV Gene Therapy. | Mol Ther Methods Clin Dev | 2020 | https://conductscience.org/library/papers/31970203 | PubMed |
| 9 | 29147032 | Emptying the stores: lysosomal diseases and therapeutic strategies. | Nat Rev Drug Discov | 2018 | https://conductscience.org/library/papers/29147032 | PubMed |
| 10 | 23689599 | Therapeutic response in feline sandhoff disease despite immunity to intracranial gene therapy. | Mol Ther | 2013 | https://conductscience.org/library/papers/23689599 | PubMed |
| 11 | 23955157 | Enzyme replacement in neuronal storage disorders in the pediatric population. | Curr Treat Options Neurol | 2013 | https://conductscience.org/library/papers/23955157 | PubMed |
| 12 | 15687347 | Substrate reduction reduces gangliosides in postnatal cerebrum-brainstem and cerebellum in GM1 gangliosidosis mice. | J Lipid Res | 2005 | https://conductscience.org/library/papers/15687347 | PubMed |
| 13 | 28577204 | The treatment of juvenile/adult GM1-gangliosidosis with Miglustat may reverse disease progression. | Metab Brain Dis | 2017 | https://conductscience.org/library/papers/28577204 | PubMed |
| 14 | 18524657 | GM1 gangliosidosis: review of clinical, molecular, and therapeutic aspects. | Mol Genet Metab | 2008 | https://conductscience.org/library/papers/18524657 | PubMed |
| 15 | 26766614 | Enzyme replacement for GM1-gangliosidosis: Uptake, lysosomal activation, and cellular disease correction using a novel β-galactosidase:RTB lectin fusion. | Mol Genet Metab | 2016 | https://conductscience.org/library/papers/26766614 | PubMed |
| 16 | 31481471 | Intracerebroventricular enzyme replacement therapy with β-galactosidase reverses brain pathologies due to GM1 gangliosidosis in mice. | J Biol Chem | 2020 | https://conductscience.org/library/papers/31481471 | PubMed |
| 17 | 17164772 | Complete correction of enzymatic deficiency and neurochemistry in the GM1-gangliosidosis mouse brain by neonatal adeno-associated virus-mediated gene delivery. | Mol Ther | 2007 | https://conductscience.org/library/papers/17164772 | PubMed |
| 18 | 28502768 | Lysosomal enzyme replacement therapies: Historical development, clinical outcomes, and future perspectives. | Adv Drug Deliv Rev | 2017 | https://conductscience.org/library/papers/28502768 | PubMed |
| 19 | 28808666 | Lipidomic Evaluation of Feline Neurologic Disease after AAV Gene Therapy. | Mol Ther Methods Clin Dev | 2017 | https://conductscience.org/library/papers/28808666 | PubMed |
| 20 | 20976108 | AAV-mediated gene delivery in adult GM1-gangliosidosis mice corrects lysosomal storage in CNS and improves survival. | PLoS One | 2010 | https://conductscience.org/library/papers/20976108 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42782580 | Single-nucleus RNA sequencing reveals excitatory and inhibitory neuronal subtype imbalance and its potential regulatory mechanisms in GM1 gangliosidosis. | Genes Genomics | 2026 | https://conductscience.org/library/papers/42782580 | PubMed |
| 42410243 | Brain aging in Type II GM1 gangliosidosis. | Commun Med (Lond) | 2026 | https://conductscience.org/library/papers/42410243 | PubMed |
| 42353850 | Infantile GM1 Gangliosidosis with Epilepsy Associated with a Same-Codon GLB1 Variant (c.808T>G/c.808T>C). | Genes (Basel) | 2026 | https://conductscience.org/library/papers/42353850 | PubMed |
| 42160923 | Diagnostic and therapeutic applications of the glycan biomarker H3N2b in GM1 Gangliosidosis. | Mol Genet Metab | 2026 | https://conductscience.org/library/papers/42160923 | PubMed |
| 42074270 | Development of Small-Molecule Allosteric Modulators of Beta-Galactosidase (β-Gal) for the Treatment of GM1 Gangliosidosis and Morquio B. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42074270 | PubMed |
| 41581874 | Gangliosides in molecular interactions and cell regulation. | J Biol Chem | 2026 | https://conductscience.org/library/papers/41581874 | PubMed |
| 40872546 | Systemic Metabolic Alterations Induced by Etodolac in Healthy Individuals. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40872546 | PubMed |
| 40485743 | DANGO: An MS data annotation tool for glycolipidomics. | BBA Adv | 2025 | https://conductscience.org/library/papers/40485743 | PubMed |
| 40462861 | Differential tractography: an imaging marker for tissue degeneration in neurodegenerative diseases. | Brain Commun | 2025 | https://conductscience.org/library/papers/40462861 | PubMed |
| 39273659 | Insights into the Pathobiology of GM1 Gangliosidosis from Single-Nucleus Transcriptomic Analysis of CNS Cells in a Mouse Model. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39273659 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| GLB1 | 2720 | PubTator's text mining | https://conductscience.org/library/genes/2720 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38737101
GET https://conductscience.org/api/papers/v1/38737101/references?page=2